Gómez-Moreno, A.; San Sebastian, E.; Moya, J.; Gomollón-Zueco, P.; Isola, S.; Vales, Á.; González-Aseguinolaza, G.; Unzu, C.; Garaigorta, U.
Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells. Pharmaceutics 2023, 15, 2459.
https://doi.org/10.3390/pharmaceutics15102459
AMA Style
Gómez-Moreno A, San Sebastian E, Moya J, Gomollón-Zueco P, Isola S, Vales Á, González-Aseguinolaza G, Unzu C, Garaigorta U.
Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells. Pharmaceutics. 2023; 15(10):2459.
https://doi.org/10.3390/pharmaceutics15102459
Chicago/Turabian Style
Gómez-Moreno, Andoni, Enara San Sebastian, Jennifer Moya, Pilar Gomollón-Zueco, Sergio Isola, África Vales, Gloria González-Aseguinolaza, Carmen Unzu, and Urtzi Garaigorta.
2023. "Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells" Pharmaceutics 15, no. 10: 2459.
https://doi.org/10.3390/pharmaceutics15102459
APA Style
Gómez-Moreno, A., San Sebastian, E., Moya, J., Gomollón-Zueco, P., Isola, S., Vales, Á., González-Aseguinolaza, G., Unzu, C., & Garaigorta, U.
(2023). Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells. Pharmaceutics, 15(10), 2459.
https://doi.org/10.3390/pharmaceutics15102459
